FdaApplication

ANDA 212693

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZYDUS LIFESCIENCES GLOBAL FZE
application_typeANDA
approval_date2023-03-07

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL

2 products